Correlation Between Akebia Ther and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akebia Ther and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akebia Ther and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akebia Ther and Checkpoint Therapeutics, you can compare the effects of market volatilities on Akebia Ther and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akebia Ther with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akebia Ther and Checkpoint Therapeutics.
Diversification Opportunities for Akebia Ther and Checkpoint Therapeutics
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Akebia and Checkpoint is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Akebia Ther and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Akebia Ther is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akebia Ther are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Akebia Ther i.e., Akebia Ther and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between Akebia Ther and Checkpoint Therapeutics
Given the investment horizon of 90 days Akebia Ther is expected to generate 0.8 times more return on investment than Checkpoint Therapeutics. However, Akebia Ther is 1.25 times less risky than Checkpoint Therapeutics. It trades about 0.25 of its potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.19 per unit of risk. If you would invest 170.00 in Akebia Ther on August 31, 2024 and sell it today you would earn a total of 36.00 from holding Akebia Ther or generate 21.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akebia Ther vs. Checkpoint Therapeutics
Performance |
| Timeline |
| Akebia Ther |
| Checkpoint Therapeutics |
Akebia Ther and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akebia Ther and Checkpoint Therapeutics
The main advantage of trading using opposite Akebia Ther and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akebia Ther position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.| Akebia Ther vs. Protalix Biotherapeutics | Akebia Ther vs. Cidara Therapeutics | Akebia Ther vs. X4 Pharmaceuticals | Akebia Ther vs. Seres Therapeutics |
| Checkpoint Therapeutics vs. Mustang Bio | Checkpoint Therapeutics vs. Reviva Pharmaceuticals Holdings | Checkpoint Therapeutics vs. Fortress Biotech Pref | Checkpoint Therapeutics vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |